Evaluation of Safety of Pomalidomide in Combination With Dexamethasone (Low Dose) in Patients With Refractory or Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
A Study of DKN-01 and Lenalidomide/Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance
- Status
- COMPLETED
- Phase
- PHASE2
Bendamustine, Lenalidomide (Revlimid®) and Dexamethasone (BRd) as 2nd-line Therapy for Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Assessment of Impact Nutritional Program During Autologous Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 2 Study of Lenalidomide to Evaluate the Efficacy in Japanese Patients With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Serum Vitamin D Levels and Peripheral Neuropathy Among Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- N/A
Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Subcutaneous (SC) Bortezomib-Regimens for Patients With RR MM Failing Prior IV Bortezomib-Containing Regimens
- Status
- TERMINATED
- Phase
- PHASE2
C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT
- Status
- COMPLETED
- Phase
- NA
Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Dovitinib Combined With Bortezomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Tissue Collection for Studies of Lymph Cancer
- Status
- RECRUITING
- Phase
- N/A
An Observational Study of Chinese Multiple Myeloma Patients Treated With Velcade
- Status
- COMPLETED
- Phase
- N/A
Lenalidomide Maintenance Therapy for Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
A Trial of ASP7487 (OSI-906) in Combination With Bortezomib for the Treatment of Relapsed Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Total Marrow Irradiation and High-dose Melphalan for Double Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2